| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/07/2005 | EP1221959B1 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods |
| 09/07/2005 | EP0973532B1 Anti-proliferative preparations |
| 09/07/2005 | CN1666105A Oncolytic viruses as phenotyping agents for neoplasms |
| 09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
| 09/07/2005 | CN1665933A Immunoconjugates for the treatment of tumours |
| 09/07/2005 | CN1665932A Vectors with modified protease-dependent tropism |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665927A Tumor-lysing virus growing selectively in tumor cells |
| 09/07/2005 | CN1665921A Adenovirus vectors for immunotherapy |
| 09/07/2005 | CN1665920A Liver engrafting cells, assays, and uses thereof |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665826A Ruthenium anticancer complexes |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665807A Novel physiolgically active substances |
| 09/07/2005 | CN1665806A Medicine compound |
| 09/07/2005 | CN1665803A Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| 09/07/2005 | CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy |
| 09/07/2005 | CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 09/07/2005 | CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665554A Compounds and method for coating surfaces in a haemocompatible manner |
| 09/07/2005 | CN1665546A Medicinal formulation in particular for treating herniated invertebral discs |
| 09/07/2005 | CN1665545A Compound ablation mixture and its use in preparation of drugs for treating tumors |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665532A Calicheamicin derivative-carrier conjugates |
| 09/07/2005 | CN1665531A Cancer vaccines and methods of using the same |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665522A Method of up-regulating tumor antigen expression using thymalfasin |
| 09/07/2005 | CN1665515A Methods for treating psychosis associated with interferon-alpha therapy |
| 09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1665493A Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1663959A Beta-glucan peptide and its preparing process and application |
| 09/07/2005 | CN1663957A Micromolecule interference RNA aiming at middle period factor gene and use thereof |
| 09/07/2005 | CN1663610A Lysozyme preparation |
| 09/07/2005 | CN1663603A Applications of tumor-placenta antigen protein and its DNA in tumor treatment |
| 09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
| 09/07/2005 | CN1663565A Application of camptothecin derivative in drug preparing process for treating marrow originate leukemia |
| 09/07/2005 | CN1217936C Heterocyclic compounds having sulfonamide |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217700C Multi-medicine medicine-resistant RNA interference medicine for resisting tumor |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/07/2005 | CN1217680C Repellent mixture for treating uterus tumor and oophoritic cyst |
| 09/07/2005 | CN1217664C Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength |
| 09/07/2005 | CN1217662C Cancer treating medicine |
| 09/07/2005 | CN1217584C Effervescent green tea extract formulation |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | US6939874 Substituted pyrimidinyl derivatives and methods of use |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/06/2005 | US6939868 Anticancer agents; skin disorders; bone disorders |
| 09/06/2005 | US6939866 Antitumor agents; skin disorders; anticancer agents |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939697 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939567 Pharmaceutical ayurvedic preparation |
| 09/06/2005 | US6939547 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 09/06/2005 | US6939541 Polypeptide for use in the treatment of viral diseases and cancer |
| 09/06/2005 | US6939532 Versatile hydrophilic dyes |
| 09/06/2005 | US6939376 Drug-delivery endovascular stent and method for treating restenosis |
| 09/06/2005 | CA2193329C Water soluble rapamycin esters |
| 09/01/2005 | WO2005080582A1 Cytoplasmic localization dna and rna |
| 09/01/2005 | WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement |
| 09/01/2005 | WO2005080394A1 4-substituted piperidine derivatives |
| 09/01/2005 | WO2005080392A1 Pyrazoloquinolone derivative and use thereof |
| 09/01/2005 | WO2005080351A1 The preparation and application of a n4-oxycarbonylcytosine derivatives |
| 09/01/2005 | WO2005080330A1 Heteroarylphenylurea derivative |
| 09/01/2005 | WO2005079843A1 Novel liposome |
| 09/01/2005 | WO2005079835A1 Anticancer agent containing bl angiostatin |
| 09/01/2005 | WO2005079824A1 Beverage or drug containing bamboo extract as main ingredient |
| 09/01/2005 | WO2005079816A1 An anti-cancer substance of polysaccharides, its preparation method and application |
| 09/01/2005 | WO2005079813A1 Composition for nkt cell activation |
| 09/01/2005 | WO2004078133A8 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 09/01/2005 | WO2003013426A3 Multivalent synthetic vaccine for cancer |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/01/2005 | US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 09/01/2005 | US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/01/2005 | US20050192328 Compounds and methods for use thereof in the treatment of viral infections |
| 09/01/2005 | US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant |
| 09/01/2005 | US20050192317 Novel diamines having a casr modulating activity |